Specialty Pharmacy Integration of Oral Fecal Microbiota Spores Enables Medication Access in Over Half of Patients with Recurrent C difficile Infection Quality improvement initiative at Henry Ford Health demonstrates streamlined workflow, rapid prior authorization, and low patient copayments; highlights opportunities for enhanced pharmacist involveme...

Another study from #MADID2025 highlighting specialty pharmacy integration of oral fecal microbiota spores enabled access in over 50% of patients with recurrent C difficile infection. #IDsky #MEDsky #rCDI

Read more: www.contagionlive.com/view/special...

...haben das unsere Freunde vom #RotaryClubDresdenInternational übernommen 💪 - DANKESEHR 💚 !!
#Ehrenamt #RotaryActionDay #MalernInDerSonne #Wäscheberge #HandsOnProject #International #RCDI

Vedanta Biosciences reveals Phase 2 VE303 results - PharmaTimes Study highlights VE303's potential in reducing recurrent CDI

#gastroenterology #VedantaBiosciences #VE303 #recurrentCDI #Phase2CONSORTIUMstudy #recurrentClostridioidesdifficileinfection #rCDI #rCDIprevention #CDIrecurrence #VE303organisms #VE303mechanisms #microbiomerestoration #microbiome #RESTORATiVE303 #CDIresistance
pharmatimes.com/news/vedanta...